Substance Use Disorder (SUD)CCappNCT07593274
Continuing Care for Justice-involved Individuals
A study testing continuing care app in people with Substance Use Disorder (SUD), run by Friends Research Institute, Inc. at 1 site in United States.
Trial summary
The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Substance Use Disorder (SUD)
- What is being tested?
- continuing care app
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteUnited States
- Study dates
- 8 May 2025to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 1) age 18 or older, 2) currently on probation or parole, 3) currently a client receiving outpatient substance use treatment at one of the three participating clinics, 4) willing to receive supplemental treatment services through a mobile app, and 5) willing to provide informed consent and complete research assessments
Who cannot join
- 1) Active medical history that may preclude participation (e.g., requires higher level of care; active psychosis; compromised comprehension)
Trial locations and contacts
1 site in 1 country.
United States1 site
Friends Research Institute
Baltimore, Maryland, 21201-5633
About this study
Official title: Continuing Care App for Justice-Involved Individuals With Substance Use Disorders
The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.
Read the detailed description
A four-week feasibility trial of the CC app with a sample individuals on probation and parole with SUDs who are receiving outpatient substance use disorder treatment will be recruited and use the app for 12 weeks during community treatment. Study participants will complete brief questionnaires at study initiation (focusing on background characteristics, treatment history, app expectations) and after the 4-week feasibility trial (focusing on their experiences with the app, usability, satisfaction, and suggestions for improvement).
- Conditions
- Substance Use Disorder (SUD)
- Being tested
- continuing care app
- Keywords
- substance use disorder, justice involved, community treatment
- Medical subject headings
- Substance-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
continuing care appDevice
continuing care app is an app on a smartphone
| Study group | Role | What they receive |
|---|---|---|
| continuing care app | Experimental | continuing care app through a mobile cell phone Receives: Device: continuing care app |
What is being measured
The primary outcome is the main question the study is designed to answer.
app usability
Questions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability.
Measured: 12 weeks post baseline
Feasibility and Satisfaction Survey
Feasibility and Satisfaction Survey (FSS) that was developed and used in our prior research and will be used to assesses feasibility and satisfaction. Questions will consist of 5-point Likert scales and open-ended questions focused on: 1) program utilization [frequency of reviewing app content], 2) overall look, feel, and experience, 3) ease of use, and 4) app content/tools (i.e., relevance, usefulness, and engagement).
Measured: 12-weeks post-baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2026
- Study start8 May 2025
- Primary completion1 Dec 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance Use Disorder (SUD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Model description
- continuing care app
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Friends Research Institute, Inc.
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Michael S Gordon, DPA, Principal investigator, Friends Research Institute, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07593274
- Sponsor's protocol ID
- FRIEND SRESEARCH_01
- Other IDs
- UG3DA058305-01
- Acronym
- CCapp
- Status last verified
- Jan 2025
- First submitted
- 12 May 2026
- Last updated
- 18 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The data is needed for a larger phase submission.
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Continuing Care App for Justice-Involved Individuals With Substance Use Disorders
- ClinicalTrials.gov ID
- NCT07593274
- Acronym / sponsor ID
- CCapp / FRIEND SRESEARCH_01
- Conditions
- Substance Use Disorder (SUD)
- Keywords
- substance use disorder, justice involved, community treatment
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Friends Research Institute, Inc.University, hospital or other
- Study start
- 8 May 2025 (actual)
- Primary completion
- 1 Dec 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 18 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.
Detailed description
A four-week feasibility trial of the CC app with a sample individuals on probation and parole with SUDs who are receiving outpatient substance use disorder treatment will be recruited and use the app for 12 weeks during community treatment. Study participants will complete brief questionnaires at study initiation (focusing on background characteristics, treatment history, app expectations) and after the 4-week feasibility trial (focusing on their experiences with the app, usability, satisfaction, and suggestions for improvement).
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- continuing care app
| Arm | Type | Receives |
|---|---|---|
| continuing care app | Experimental | Device: continuing care appcontinuing care app through a mobile cell phone |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 1) age 18 or older, 2) currently on probation or parole, 3) currently a client receiving outpatient substance use treatment at one of the three participating clinics, 4) willing to receive supplemental treatment services through a mobile app, and 5) willing to provide informed consent and complete research assessments
Key exclusion criteria (1 listed)
- 1) Active medical history that may preclude participation (e.g., requires higher level of care; active psychosis; compromised comprehension)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| continuing care appcontinuing care app is an app on a smartphone | Device | continuing care app |
Primary outcome
app usability
Time frame: 12 weeks post baseline
Questions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability.
Feasibility and Satisfaction Survey
Time frame: 12-weeks post-baseline
Feasibility and Satisfaction Survey (FSS) that was developed and used in our prior research and will be used to assesses feasibility and satisfaction. Questions will consist of 5-point Likert scales and open-ended questions focused on: 1) program utilization [frequency of reviewing app content], 2) overall look, feel, and experience, 3) ease of use, and 4) app content/tools (i.e., relevance, usefulness, and engagement).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2026.
- Individual participant dataSharing planned: Undecided. The data is needed for a larger phase submission.
Related trials for Substance Use Disorder (SUD)
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Active, not recruitingObservational study
Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
Substance Use Disorder (SUD)
Enrolling by invitation
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Schizophrenia Disorder, Schizoaffective Disorder
Recruiting
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
Substance Use Disorder (SUD)
Not yet recruitingEarly Phase 1
Research Investigating Drug Effects-2 (RiDE-2)
Cannabis Use, Substance Use Disorder (SUD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michael S Gordon, DPA principal investigator
Friends Research Institute, Inc.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing continuing care app in people with Substance Use Disorder (SUD), run by Friends Research Institute, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
app usability (time frame: 12 weeks post baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.